AVITA MEDICAL INC (RCEL) Stock Cash Flow
NASDAQ:RCEL - Nasdaq - US05380C1027 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -57.05M | -61.84M | -35.38M | -26.67M | -26.58M | |||
| Depreciation Amortization | 1.44M | 1.13M | 632.00K | 570.00K | 720.00K | |||
| Change In Working Capital | 1.81M | -4.68M | -6.57M | -1.20M | -7.36M | |||
| Interest Paid | 5.24M | 5.36M | 1.14M | 20.00K | 0.00 | |||
| Taxes Paid | 24.00K | 41.00K | 44.00K | 20.00K | 40.00K | |||
| Other non cash items | 15.41M | 16.46M | 3.31M | 8.20M | 7.32M | |||
| OPERATING CASH FLOW | -38.38M | -48.94M | -38.01M | -19.09M | -25.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -8.24M | -9.17M | -1.38M | -450.00K | -1.17M | |||
| Other Investing Activity | 41.31M | 46.53M | 2.99M | -18.88M | -49.55M | |||
| INVESTING CASH FLOW | 33.06M | 37.36M | 1.61M | -19.33M | -1.17M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 38.76M | 0.00 | -10.00K | |||
| Stock Issued/Repurchased | 3.24M | 3.51M | 1.61M | 900.00K | 69.17M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -5.11M | |||
| FINANCING CASH FLOW | 3.24M | 3.51M | 40.37M | 900.00K | 64.05M | |||
| Exchange Rate Effect | N/A | N/A | -16.00K | -30.00K | 130.00K | |||
| CHANGE IN CASH | -2.08M | -8.07M | 3.95M | -37.55M | 37.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -38.38M | -48.94M | -38.01M | -19.09M | -25.90M | |||
| Capital Expenditure | -8.24M | -9.17M | -1.38M | -450.00K | -1.17M | |||
| FREE CASH FLOW | -46.63M | -58.11M | -39.39M | -19.54M | -27.07M | |||
All data in USD